Onychomycosis Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Moberg Pharma, Blueberry Therapeutics, Hallux, Pfizer,Moberg Pharma AB, Polichem S.A., Nitric BioTherapeutics

DelveInsight's "Onychomycosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Onychomycosis, historical and forecasted epidemiology as well as the Onychomycosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Onychomycosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Onychomycosis Market Forecast

Some of the key facts of the Onychomycosis Market Report: https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• The Onychomycosis market size was valued approximately USD 1,757 Million in 2022 in the and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• By aggregating the instances in the various nations, the total prevalence cases in the 7MM were determined. The estimated number of onychomycosis cases worldwide (7MMprevalent cases) in 2022 was close to 85,435,000, with the majority of cases being found in the US
• More than 13,390,000 instances of onychomycosis were diagnosed in total in the EU4 and UK markets in 2022, and this number is anticipated to climb during the projection period (2023-2022)
• France has the greatest number of onychomycosis diagnoses throughout all of Europe in 2022
• More than 12,763,000 cases of prevalent disease were reported in Japan in 2022.
• Key Onychomycosis Companies: Moberg Pharma, Blueberry Therapeutics, Hallux, Pfizer,Moberg Pharma AB, Polichem S.A., Nitric BioTherapeutics, Inc, Repolar Ltd., GlaxoSmithKline, Hisamitsu Pharmaceutical Co., Inc., Moberg Pharma AB, Bausch Health Americas, Inc, Halcygen Pharmaceuticals Limited, Pfizer, Viamet, Novartis, Taro Pharma, Bayer, Dow Pharma, Janssen Korea, Ltd., and others
• Key Onychomycosis Therapies: MOB-015, BB2603, HSG, Tavaborole 5%:, MOB015B, P-3058, Terbinafine HCl, Resin Lacquer, Albaconazole, HTU-520, MOB015, Efinaconazole, SUBA-itraconazole, AN2690, VT-1161, terbinafine, NVXT topical, SCH 56592, Bifonazole cream 1%, IDP-108, Itraconazole, and others
• The Onychomycosis epidemiology based on gender analyzed that Onychomycosis is more common in females than males, in the United States
• The Onychomycosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Onychomycosis pipeline products will significantly revolutionize the Onychomycosis market dynamics.

Onychomycosis Overview
The most prevalent nail infection in the world, onychomycosis is a fungal infection that thickens and discolors the nail plate. However, recent studies have shown that mixed infections including those caused by nondermatophyte moulds (NDMs) are more common than previously believed, especially in warmer areas. Dermatophytes were once assumed to be the primary cause of onychomycosis.

Get a Free sample for the Onychomycosis Market Report
https://www.delveinsight.com/report-store/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Onychomycosis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Onychomycosis Epidemiology Segmentation:
The Onychomycosis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Onychomycosis
• Prevalent Cases of Onychomycosis by severity
• Gender-specific Prevalence of Onychomycosis
• Diagnosed Cases of Episodic and Chronic Onychomycosis

Download the report to understand which factors are driving Onychomycosis epidemiology trends @ Onychomycosis Epidemiology Forecast
https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Onychomycosis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Onychomycosis market or expected to get launched during the study period. The analysis covers Onychomycosis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Onychomycosis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Onychomycosis Therapies and Key Companies
• MOB-015: Moberg Pharma
• BB2603: Blueberry Therapeutics
• HSG: Hallux
• Tavaborole 5%: Pfizer
• MOB015B: Moberg Pharma AB
• P-3058: Polichem S.A.
• Terbinafine HCl: Nitric BioTherapeutics, Inc
• Resin Lacquer: Repolar Ltd.
• Albaconazole: GlaxoSmithKline
• HTU-520: Hisamitsu Pharmaceutical Co., Inc.
• P-3058: Polichem S.A.
• MOB015: Moberg Pharma AB
• Efinaconazole: Bausch Health Americas, Inc
• SUBA-itraconazole: Halcygen Pharmaceuticals Limited
• AN2690: Pfizer
• VT-1161: Viamet
• terbinafine: Novartis
• NVXT topical: Taro Pharma
• SCH 56592: Merck Sharp & Dohme LLC
• Bifonazole cream 1%: Bayer
• IDP-108: Dow Pharma
• Itraconazole: Janssen Korea, Ltd.

Discover more about therapies set to grab major Onychomycosis market share @ Onychomycosis Treatment Market
https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Onychomycosis Market Strengths
• The introduction of novel, inexpensive, and non-invasive diagnostic technologies have led to rapid and accurate diagnosis of onychomycosis, hence increased the rate of diagnosis

Onychomycosis Market Opportunities
• Current treatments have poor adherence and tolerability creating an opportunity for the key players to work on these areas

Scope of the Onychomycosis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Onychomycosis Companies: Moberg Pharma, Blueberry Therapeutics, Hallux, Pfizer,Moberg Pharma AB, Polichem S.A., Nitric BioTherapeutics, Inc, Repolar Ltd., GlaxoSmithKline, Hisamitsu Pharmaceutical Co., Inc., Moberg Pharma AB, Bausch Health Americas, Inc, Halcygen Pharmaceuticals Limited, Pfizer, Viamet, Novartis, Taro Pharma, Bayer, Dow Pharma, Janssen Korea, Ltd., and others
• Key Onychomycosis Therapies: MOB-015, BB2603, HSG, Tavaborole 5%:, MOB015B, P-3058, Terbinafine HCl, Resin Lacquer, Albaconazole, HTU-520, MOB015, Efinaconazole, SUBA-itraconazole, AN2690, VT-1161, terbinafine, NVXT topical, SCH 56592, Bifonazole cream 1%, IDP-108, Itraconazole, and others
• Onychomycosis Therapeutic Assessment: Onychomycosis current marketed and Onychomycosis emerging therapies
• Onychomycosis Market Dynamics: Onychomycosis market drivers and Onychomycosis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Onychomycosis Unmet Needs, KOL's views, Analyst's views, Onychomycosis Market Access and Reimbursement

To know more about Onychomycosis companies working in the treatment market, visit @ Onychomycosis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/onychomycosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Onychomycosis Market Report Introduction
2. Executive Summary for Onychomycosis
3. SWOT analysis of Onychomycosis
4. Onychomycosis Patient Share (%) Overview at a Glance
5. Onychomycosis Market Overview at a Glance
6. Onychomycosis Disease Background and Overview
7. Onychomycosis Epidemiology and Patient Population
8. Country-Specific Patient Population of Onychomycosis
9. Onychomycosis Current Treatment and Medical Practices
10. Onychomycosis Unmet Needs
11. Onychomycosis Emerging Therapies
12. Onychomycosis Market Outlook
13. Country-Wise Onychomycosis Market Analysis (2019-2032)
14. Onychomycosis Market Access and Reimbursement of Therapies
15. Onychomycosis Market Drivers
16. Onychomycosis Market Barriers
17. Onychomycosis Appendix
18. Onychomycosis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Onychomycosis Pipeline https://www.delveinsight.com/report-store/onychomycosis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Onychomycosis Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Onychomycosis market. A detailed picture of the Onychomycosis pipeline landscape is provided, which includes the disease overview and Onychomycosis treatment guidelines.
Onychomycosis Epidemiology https://www.delveinsight.com/report-store/onychomycosis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Onychomycosis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Onychomycosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight

Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.